Management of Children With or Exposed to HIV

  • Authors: James A. McAuley, MD, MPH; Mariam Aziz, MD (More Info)
  • Associate Editor: Judith S. Currier, MD, MSc
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 7/12/18 (What's New)

Summary

  • Current DHHS guidelines recommend that 4-week neonatal zidovudine can be used in infants of mothers who received standard combination ART during pregnancy with continuous virologic suppression and no maternal adherence concerns[DHHS Perinatal]
    • Frequency of hematologic monitoring should be based on specific circumstances of each case[DHHS Perinatal]
    • If anemia or other hematologic abnormalities occur, the decision to stop or continue prophylaxis should be individualized, and consultation with a pediatric HIV infection expert is recommended[DHHS Perinatal]

Action required